Driving standard of care for a market-leading prostate cancer test
Myriad’s Prolaris team, focused on sales of prostate cancer molecular testing, was concerned about leveling sales and having limited success in achieving standard of care. We identified the barriers and market-validated the methods and assets needed to overcome those barriers. The results were accelerated sales per urologist, as well as an increase in total urologists […]
Designing a virtual pet therapy app that brings comfort, choice, and companionship to care settings
Pet therapy is proven to ease stress, anxiety, and isolation—especially in clinical settings like hospitals, behavioral health facilities, and senior care. But in-person visits are often limited by staffing, scheduling, and infection control. Notenda was engaged to create a digital alternative: a virtual pet therapy app that feels personal, playful, and emotionally real. Working closely […]
Mining Consumer & Patient Sentiment for Product Design
AI interprets reviews and behavior to guide faster, more informed product decisions: This AI startup wanted to help product teams move faster—by transforming how they interpret feedback from the market. Instead of relying on lagging metrics like star ratings or formal surveys, they built a tool that listens to what people are actually saying: in […]
AI-Enabled Health Record Assistant
Transforms health history for patients into clear, actionable insights through conversational AI: A digital health startup asked: What if anyone could understand their own medical records—without needing a physician to explain them? With rising demand for accessible care guidance, they envisioned an AI-powered experience that could interpret a person’s health history and surface relevant next […]
Business strategy and fundraising for a global NGS company
We collaborated with executive management to shape and deliver the combined corporate and fundraising strategy, founded in a positioning as a global platform both enabling and delivering solutions across all of genomics and the globe. Results included a raise of $240M and a growing portfolio of seven businesses.